Trinity Biotech PLC Files August 2024 6-K Report
Ticker: TRIB · Form: 6-K · Filed: Aug 20, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Aug 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Trinity Biotech PLC filed its monthly 6-K report, standard procedure, no major news.
AI Summary
Trinity Biotech plc filed a Form 6-K on August 20, 2024, to report its activities for the month of August 2024. The company, an Irish-based issuer of diagnostic substances, is required to file this report under the Securities Exchange Act of 1934. This filing indicates ongoing compliance and reporting obligations for the company.
Why It Matters
This filing is a routine report for foreign private issuers, indicating ongoing operational and reporting activities for Trinity Biotech plc. It does not contain specific financial results or material events but confirms their compliance with SEC regulations.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial information or strategic changes.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- 0000888721 (company) — Central Index Key
- 2835 (company) — Standard Industrial Classification
- August 2024 (date) — Reporting period
- 20240820 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the registrant may be required to disclose or make public pursuant to the laws of its home country or jurisdiction, or which it may be required to file with or submit to any stock exchange on which it has securities listed.
What is the filing date of this specific Form 6-K?
This Form 6-K was filed on August 20, 2024.
What is the principal executive office address of Trinity Biotech plc?
The principal executive office is located at IDA Business Park, Bray, Co. Wicklow, Ireland.
Does Trinity Biotech plc file annual reports under Form 20-F or Form 40-F?
Trinity Biotech plc indicates it files annual reports under cover of Form 20-F.
What industry does Trinity Biotech plc operate in?
Trinity Biotech plc operates in the 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' industry, classified under SIC code 2835.
Filing Stats: 309 words · 1 min read · ~1 pages · Grade level 12.1 · Accepted 2024-08-20 13:52:48
Filing Documents
- zk2431900.htm (6-K) — 18KB
- exhibit_99-1.htm (EX-99.1) — 518KB
- image1.jpg (GRAPHIC) — 90KB
- 0001178913-24-002706.txt ( ) — 662KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ John Gillard John Gillard Chief Executive Officer Date: August 20, 2024